Patients who fail initial treatment with methotrexate have a greater reduction in disease activity if switched to a biological rather than conventional synthetic DMARD, results from a ‘real world’ study suggest. In a one year follow up of 512 patients with newly diagnosed RA, Dutch researchers found that those who switched to a bDMARD had ...
How to treat RA patients when methotrexate has failed?
By Michael Woodhead
20 Nov 2018